Semaglutide versus dulaglutide once weekly in patients with Type 2 diabetes (SUSTAIN 7): A randomised, open-label, phase 3b trial, The Lancet Diabetes & Endocrinology (2018) Ozempic semaglutide injection, solution, DailyMed (2024) Trulicity dulaglutide injection, solution, DailyMed (2024) Clinical recommendations to manage gastrointestinal adverse events in patients treated with Glp-1 receptor agonists: a multidisciplinary expert consensus, Journal of Clinical Medicine (2022) Possible side effects of Ozempic (semaglutide) injection, Novo Nordisk An indirect treatment comparison of the efficacy of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg, Diabetes, Obesity and Metabolism (2021) SUSTAIN 7: Ozempic versus Trulicity, NovoMedlink Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
The combination of astaxanthin and karanja oil provides enhanced skin protection against UV rays
Most studies included MACE as the primary cardiovascular outcome, whereas kidney outcomes varied across studies
Women With Polycystic Ovary Syndrome (PCOS) PCOS affects an estimated 6-12% of reproductive-age women in the United States, according to the CDC
Substance use disorders remain a major global health challenge
